Conference Coverage
Conference Coverage
Endoscopic severity score helps guide treatment in immune-mediated colitis
The scoring system could assist with accurate severity assessment and choice of medical treatment.
Conference Coverage
Guselkumab induction improves moderate to severe active UC at week 12
The drug was statistically superior to the placebo across all key endpoints in phase 2b study, regardless of patient response or intolerance to...
Conference Coverage
Dupilumab improves eosinophilic esophagitis up to 24 weeks
The drug received FDA approval for EoE treatment earlier in 2022.
Conference Coverage
Thyroid dysfunction may linger a year after severe COVID-19
The implications of the atypical thyroiditis areas, which tend to be asymptomatic, are unclear.
Conference Coverage
NAFLD progresses to cirrhosis in young and old at similar rate
Risk factors for NAFLD vary with age, but all patients experience similar progression of advanced disease once it develops.
Conference Coverage
Research ties gout in women to comorbidities more than genetics
Research suggests a link between cardiometabolic comorbidities and obesity and gout in women, with genetic traits seen playing a lesser role.
Latest News
An integrative approach to atopic dermatitis features a long list of options
Dr. Lio has three main criteria, or “filters,” for complementary or alternative treatments: At least some clinical evidence for efficacy (...
Conference Coverage
Findings may be practice changing for early breast cancer patients
A radiation boost to the tumor bed during whole breast irradiation was as safe and effective as delivering the boost sequentially.
Conference Coverage
ctDNA hints at esophageal cancer outcomes
Reductions in ctDNA were associated with better progression-free and overall survival.
Latest News
Radiotherapy shows benefit in difficult liver cancer cases
SBRT combined with sorafenib led to a strong survival benefit versus sorafenib alone in a difficult to treat liver cancer.
Conference Coverage
Terlipressin decreases need for renal replacement therapy in liver transplant recipients
The drug restores renal blood flow and reverses hepatorenal syndrome type 1 in some patients.